Fujian Haixi Pharmaceuticals Co., Ltd. (stock code: 02637) published its monthly return on movements in securities for the period ended 28 February 2026. The announcement indicates that the total authorised share capital remains at 78.71 million shares with a par value of RMB1 each, amounting to RMB78.71 million in total. No increase or decrease was recorded for the month.

The number of issued shares also stands at 78.71 million, with no treasury shares during the reporting period. According to the announcement, the applicable public float requirement of 25% was met. No share options, warrants, convertible securities, or other arrangements to issue shares were reported.

The return was submitted on 05 March 2026 by Joint Company Secretary, Mr. Zhang Junhuan. No other changes in share capital were disclosed for February 2026.